Kite Pharma, Inc. Proceeds from Stock Options Exercised
Kite Pharma, Inc. reported Proceeds from Stock Options Exercised of $30.29 million for the 6-month period ending 2017-06-30, per its 10-Q filed 2017-08-08.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromStockOptionsExercised · last filed 2017-08-08
- Kite Pharma, Inc. proceeds from stock options exercised for the quarter ending 2017-06-30 was $13.71M, a 2653.01% increase year-over-year.
- Kite Pharma, Inc. proceeds from stock options exercised for the quarter ending 2017-03-31 was $16.58M, a 3361.38% increase year-over-year.
- Kite Pharma, Inc. proceeds from stock options exercised for the quarter ending 2016-12-31 was $248.00K, a 94.06% decline year-over-year.
- Kite Pharma, Inc. proceeds from stock options exercised for the quarter ending 2016-09-30 was $2.49M, a 19.18% increase year-over-year.
- Kite Pharma, Inc. proceeds from stock options exercised for fiscal 2016 was $3.71M, a 46.67% decline from fiscal 2015.
- Kite Pharma, Inc. proceeds from stock options exercised for fiscal 2015 was $6.96M, a 136.75% increase from fiscal 2014.
- Kite Pharma, Inc. proceeds from stock options exercised for fiscal 2014 was $2.94M.
- Kite Pharma, Inc. proceeds from stock options exercised for fiscal 2012 was $5.00K.
| Period end | Proceeds from Stock Options Exercised 3 month | Proceeds from Stock Options Exercised 6 month | Proceeds from Stock Options Exercised 9 month | Proceeds from Stock Options Exercised 12 month |
|---|---|---|---|---|
| 2017-06-30 | $13.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $30.29M 10-Q · filed 2017-08-08 | $30.54M derived: sum of 3 quarters · filed 2017-08-08 | $33.02M derived: sum of 4 quarters · filed 2017-08-08 |
| 2017-03-31 | $16.58M 10-Q · filed 2017-05-08 | $16.83M derived: sum of 2 quarters · filed 2017-05-08 | $19.31M derived: sum of 3 quarters · filed 2017-05-08 | $19.81M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-12-31 | $248.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $2.73M derived: sum of 2 quarters · filed 2017-02-28 | $3.23M derived: sum of 3 quarters · filed 2017-08-08 | $3.71M 10-K · filed 2017-02-28 |
| 2016-09-30 | $2.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.98M derived: sum of 2 quarters · filed 2017-08-08 | $3.46M 10-Q · filed 2016-11-09 | $7.64M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-06-30 | $498.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $977.00K 10-Q · filed 2017-08-08 | $5.16M derived: sum of 3 quarters · filed 2017-08-08 | $7.24M derived: sum of 4 quarters · filed 2017-08-08 |
| 2016-03-31 | $479.00K 10-Q · filed 2017-05-08 | $4.66M derived: sum of 2 quarters · filed 2017-05-08 | $6.74M derived: sum of 3 quarters · filed 2017-05-08 | $7.37M derived: sum of 4 quarters · filed 2017-05-08 |
| 2015-12-31 | $4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $6.26M derived: sum of 2 quarters · filed 2017-02-28 | $6.89M derived: sum of 3 quarters · filed 2017-02-28 | $6.96M 10-K · filed 2017-02-28 |
| 2015-09-30 | $2.09M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $2.71M derived: sum of 2 quarters · filed 2016-11-09 | $2.78M 10-Q · filed 2016-11-09 | $2.79M derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-06-30 | $625.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-08 | $694.00K 10-Q · filed 2016-08-08 | $700.00K derived: sum of 3 quarters · filed 2017-02-28 | $715.00K derived: sum of 4 quarters · filed 2017-02-28 |
| 2015-03-31 | $69.00K 10-Q · filed 2016-05-09 | $75.00K derived: sum of 2 quarters · filed 2017-02-28 | $90.00K derived: sum of 3 quarters · filed 2017-02-28 | $2.96M derived: sum of 4 quarters · filed 2017-02-28 |
| 2014-12-31 | $6.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | $21.00K derived: sum of 2 quarters · filed 2017-02-28 | $2.89M derived: sum of 3 quarters · filed 2017-02-28 | $2.94M 10-K · filed 2017-02-28 |
| 2014-09-30 | $15.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-12 | $2.88M derived: sum of 2 quarters · filed 2015-11-12 | $2.93M 10-Q · filed 2015-11-12 | |
| 2014-06-30 | $2.87M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $2.92M 10-Q · filed 2015-08-10 | ||
| 2014-03-31 | $52.00K 10-Q · filed 2015-05-15 | |||
| 2012-12-31 | $5.00K 10-K · filed 2015-03-26 |